Hopp til hovedinnhold
Bildet viser mild rosacea. Behandling av rosacea består av symptomlindrende medikamenter samt å unngå faktorer som kan utløse plagene.
Bildet viser mild rosacea. Behandling av rosacea består av symptomlindrende medikamenter samt å unngå faktorer som kan utløse plagene.

Rosacea

Rosacea er en kronisk betennelse som gir rødhet i huden i ansiktet. Symptomer starter med anfallsvis rødming (flushing) med varighet ca. fem minutter. Kviser og hevelser kan etter hvert tilkomme.

Sist revidert:
QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/hud/pussholdig-utslett-ekskl-akne/rosacea/ 

Hva er rosacea?

Undertyper

Årsaker

Diagnosen

Behandling

Egenbehandling

Medikamenter

Prognose

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Rosacea. Referanselisten for dette dokumentet vises nedenfor.

  1. van Zuuren EJ. Rosacea. N Engl J Med 2017; 377: 1754-64. pmid:29091565 PubMed 
  2. Oge LK, Muncie HL, Phillips-Savoy AR. Rosacea: Diagnosis and treatment. Am Fam Physician. 2015 Aug 1;92(3):187-196.
  3. Barakji YA, Rønnstad ATM, Christensen MO et al. Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea: A Systematic Review and Meta-analysis. JAMA Dermatol. 2022 Apr 6. Epub ahead of print. PMID: 35385049. PubMed 
  4. Helsedirektoratet. Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Sist faglig oppdatert: 16. november 2021.
  5. Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol. 2012;167(3):598–605.
  6. Yang X. Relationship between Helicobacter pylori and Rosacea: review and discussion. BMC Infect Dis. 2018 Jul 11;18(1):318. PMID: 29996790 PubMed 
  7. Gravina AG, Federico A, Ruocco E, et al. Helicobacter pylori infection but not small intestinal overgrowth may play a pathogenetic role in rosacea. United European Gastroenterology Journal 2015; 3: 17-24. doi:10.1177/2050640614559262 DOI 
  8. Yamasaki K, Di Nardo A, Bardan A et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 975-81. PubMed 
  9. Whitfeld M, Gunasingam N, Leow JL, et al. Staphylococcus epidermidis: A possible role in the pustules of rosacea. J Am Acad Dermatol 2011; 64(1): 49-52. PMID: 20943287 PubMed 
  10. Aroni K, Tsagroni E, Kavantzas N, et al. Study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res 2008; 300: 125-31. pmid:18071725 PubMed 
  11. Jarell, AD. Rosacea. BMJ Best Practice. Last reviewed 30 Sep, 2020. bestpractice.bmj.com 
  12. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6 suppl 1):S15–S26.
  13. Gallo RL, Granstein RD, Kang S, et al. Rosacea comorbidities and future research: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):167-170. PMID: 29102687 PubMed 
  14. Zierl S, Hildebrand JA, Guertler A et al. Clinical clues to identify patients with ocular rosacea - a Germany-wide epidemiologic analysis. Int J Dermatol. 2022 Jul;61(7):880-885.Epub 2022 May 17. PMID: 35579395 PubMed 
  15. Su D, Drummond PD. Blushing propensity and psychological distress in people with rosacea. Clin Psychol Psychother. 2012;19(6):488-95. PMID: 21698719 PubMed 
  16. Oge' LK, Muncie HL, Phillips-Savoy AR. Rosacea: Diagnosis and Treatment. Am Fam Physician. 2015;92(3):187-196. PubMed 
  17. Huldt-Nystrøm T, Danielsen K, Li X, Stangeland KZ. Rosacea. Tidsskr Nor Legeforen 3. oktober 2017. doi: 10.4045/tidsskr.16.0657 DOI 
  18. Maier LE. Management of rosacea. UpToDate, last updated Feb 24, 2020. UpToDate 
  19. van Zuuren EJ, Fedorowicz Z, Carter B, et al. Interventions for rosacea. Cochrane Database of Systematic Reviews 2015, Issue 4. Art. No.: CD003262. DOI: 10.1002/14651858.CD003262.pub5. DOI 
  20. van Zuuren EJ, Fedorowicz Z, Tan J et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol. 2019 Jul;181(1):65-79. Epub 2019 Mar 10. PMID: 30585305 PubMed 
  21. Gollnick H, Blume-Peytavi U, Szabó EL et al. Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 2010; 8: 505 - 15. PubMed 
  22. Wang B, Huang Y, Tang Y, Zhao Z, Shi W, Jian D, Liu F, Gao Q, Wang P, Yang J, Li L, Xie H, Li J. Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial. J Am Acad Dermatol. 2023 Jun;88(6):1300-1307. Epub 2023 Feb 15. PMID: 36806645. PubMed 
  23. Bernstein EF, Schomacker K, Paranjape A, Jones CJ. Pulsed dye laser treatment of rosacea using a novel 15 mm diameter treatment beam. Lasers Surg Med. 2018 Oct;50(8):808-812. Epub 2018 Apr 10. PMID: 29635699 PubMed 
  24. Tanghetti E, Del Rosso JQ, Thiboutot D, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities and devices. Cutis. 2014;93(2):71–76.
  25. Krausz AE, Goldberg DJ, Ciocon DH, Tinklepaugh AJ. Procedural management of rhinophyma: A comprehensive review. J Cosmet Dermatol 2018; 17: 960-7. pmid:30225926 PubMed 
  26. Cuevas P, Angulo J, Giménez-Gallego G. Long term effectiveness of dobesilate in the treatment of papulopustular rosacea. BMJ Case Reports 2012; : doi:10.1136/bcr.08.2011.4579 . DOI 
  27. Hua TC, Chung PI, Chen YJ, et al. Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan. J Am Acad Dermatol 2015; 73: 249-54. DOI: 10.1016/j.jaad.2015.04.028 DOI